Search News All categories Breath Biopsy Cancer Clinical Trials Company Updates COVID-19 Exposure Research FAIMS Gut & Digestion Liver Lung & Respiratory Media Mentions Press Releases Science & Research All products Breath Biopsy® Collection Station ReCIVA® Breath Sampler Breath Biopsy® Kits CASPER® Portable Air Supply Breath Biopsy Services Lonestar® VOC Analyzer ATLAS Headspace Sampler ultraFAIMS™ FILTER LIST Breath Biopsy Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the close of its Series D financing round, securing $58 million and bringing the total raised by the company to over $150 million since founding in 2016. 07 Sep 21 COMPANY UPDATES Owlstone Medical Appoints Mark Capone to Board of Directors 16 Sep 21 COVID-19 Owlstone Medical Publishes Data on the Use of Face Mask Filters to Capture Viral Particles for SARS-CoV-2 Detection 20 Jul 21 BREATH BIOPSY Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic 18 May 21 BREATH BIOPSY Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases 19 Jan 21 COMPANY UPDATES Owlstone Medical Expands U.S. Operations and Establishes Permanent U.S. Office 11 Dec 20 BREATH BIOPSY Owlstone Medical Announces Key Study Results on use of Breath Biopsy for Improved Detection of Liver Disease including NASH and NAFLD 22 Sep 20 BREATH BIOPSY DRAGON: A new international project funded by IMI and supported through the European Commission’s Horizon 2020 Framework Programme for Research and Innovation to develop a diagnostics tool combatting coronavirus infections. 13 May 20 COMPANY UPDATES Owlstone Medical Appoints Neil Tween as Chief Financial Officer 30 Mar 20 COMPANY UPDATES Owlstone Medical named as one of FierceMedTech’s “Fierce 15” companies of 2019 09 Mar 20 BREATH BIOPSY Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure 10 Dec 19 BREATH BIOPSY Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-Invasive Breath Biopsy 07 Nov 19 BREATH BIOPSY Owlstone Medical to Contribute Breath Biopsy to 3TR, the Largest-ever IMI2 Immunology Project to Improve Disease Management Across Seven Immune-Mediated Diseases 29 Oct 19 1 2 3 4 5 6 7 Talk to us about your biomarker research and how Breath Biopsy could help. CONTACT US Owlstone Medical is developing a breathalyzer for disease for the early detection of cancer, inflammatory and infectious disease. Our mission is to save 100,000 lives and $1.5B in healthcare costs. CONTACTS Cambridge, UK (Visiting): +44 (0)1223 428200 Cambridge, UK: +44 (0)1223 428200 North Carolina, USA: 984-244-7811 Connecticut, USA: +1 203-908-4848 Get in touch with us CONNECT WITH US CONTACT US Twitter LinkedIn Facebook Owlstone Medical's Products and Services are for research use only. Not for use in diagnostic procedures. © Owlstone Medical Ltd 2021 Privacy Policy Cookie Policy Legal Notice and Other Policies Designed & built by Onespacemedia